For the last few days, Kenyans living with HIV&AIDS have been warned of lack of ARV's in the country, which has caused alot of distress among these patients. Millions of then who rely on them to prolong their living have since cried to the government to help them get these essential tablets .
However, the embattled jibilee part nominated senator Hon Millicent Omanga has spilled the bean on the real cause of decreased ARV's in the country. According to Omanga, the well wishers who help the country with such medicines have been slapped with a 90 million shillings for skipping protocols.
According to Omanga, the much needed ARv's are stuck at the port yet the citizens of Kenya are suffering. The donors skipped KEMSA , may be for its involvement in the huge loss of covid 19 billions.
The government should therefore sympathize with the suffering Kenyans and immediately release the ARV's as they follow the procedure breach by the said donors.
Content created and supplied by: muuganews (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More